A

Acadia Pharmaceuticals

Develops and commercializes CNS disorder therapies

Senior Medical Director

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in ItalyNo salary listedRemote

About the Job

Requirements

  • An MD, PharmD, PhD, or equivalent advanced degree in life sciences.
  • A background in neurology, paediatric neurology, neurodevelopmental disorders, or rare diseases is strongly preferred.
  • At least 10 years of experience in Medical Affairs, Patient Advocacy, or related roles within biotech or smaller pharmaceutical companies.
  • Experience in pre-launch and launch medical activities, ideally in a first-in-class or early-stage product environment, is a strong plus.
  • Strong experience in rare diseases and/or neurodevelopmental disorders.
  • Ability to work independently, entrepreneurially, and cross-functionally in a lean organization.
  • Deep understanding of the Italian healthcare system, reference centers, and national rare disease networks.
  • Ability to work hands-on, adapt, and operate comfortably amid ambiguity.
  • Cross-functional understanding and collaboration.
  • Scientific credibility and ability to influence without authority.
  • Excellent communication skills in Italian and English.
  • High ethical standards and strong understanding of medical compliance in Italy and the European Union.

Responsibilities

  • Develop and own the Italian medical strategy for Rett syndrome from pre-launch through launch and post-launch, including budget responsibilities.
  • Align the European scientific vision and strategy with practical, locally relevant medical plans aligned with Italian clinical practice and patient pathways.
  • Act as the single-country medical authority for Rett syndrome, representing the company externally and internally with the country medical affairs and cross-functional team.
  • Design and coordinate or execute disease-education and unmet-need medical initiatives ahead of national product approval, aligned with the launch-readiness plan.
  • Lead medical launch readiness, including scientific narratives, medical materials, and internal training, aligned with the cross-functional launch-readiness plan in collaboration with the European Regional Medical team and local cross-functional team.
  • Partner with Commercial, Market Access, Compliance, and Regulatory colleagues to ensure a cohesive, compliant launch.
  • Further develop Italy-wide KOL networks and expert centers, and multidisciplinary Rett syndrome care teams, aligned with the cross-functional engagement plan.
  • Together with country medical colleagues, lead scientific exchanges at medical conferences, advisory boards, and expert meetings, often acting as the primary scientific presenter.
  • Support congress planning, abstracts, and publications relevant to Rett syndrome.
  • Support and increase established, trusted, long-term partnerships with Italian Rett syndrome patient and caregiver organizations together with country medical staff.
  • Integrate the patient and caregiver perspective into medical strategy, education, and evidence generation.
  • Collaborate ethically with patient advocacy groups on disease awareness, diagnostic journeys, and unmet needs, in line with Italian and European Union compliance standards.
  • Contribute to the design and execution of real-world evidence, registries, and post-marketing studies in Italy, including Investigator Initiated Studies, as applicable.
  • Support and drive national publication strategies and scientific communication activities.
  • Help establish medical governance, standard operating procedures, and compliant ways of working in Italy, appropriate for a growing biotech organization.
  • Act as a key medical strategic partner to the General Manager, cross-functional team, and senior leadership on scientific, clinical, and medical patient-centric decisions related to Italy.
  • Support the build-out of the Italian medical function, including future hiring, vendor selection, and process development, as needed.
  • Be an active member of the local leadership team and European Medical Team.

Desired Qualifications

  • A background in neurology, paediatric neurology, neurodevelopmental disorders, or rare diseases.
  • Experience in pre-launch and launch medical activities, ideally in a first-in-class or early-stage product environment.

About the Company

Acadia Pharmaceuticals

Develops and commercializes CNS disorder therapies

ACADIA Pharmaceuticals develops and commercializes medicines for central nervous system (CNS) disorders, focusing on neurological and psychiatric conditions with unmet medical needs. Its work centers on identifying drug candidates, advancing them through preclinical and clinical trials, and, upon regulatory approval, bringing therapies to market. Its products address CNS conditions such as Parkinson's disease psychosis, reflecting a commitment to treating complex brain disorders. The company combines in-house research with potential strategic collaborations to expand its portfolio and reach. Unlike peers that rely on a single development path, ACADIA emphasizes a broad pipeline and the ability to commercialize approved therapies, aiming to provide effective CNS treatments to patients and improve outcomes in mental health and neuroscience.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Diego, CA
Founded
1993

Recently Posted Jobs

Explore more opportunities at Acadia Pharmaceuticals

See more jobs